Aditxt, Inc. (ADTX) vs OSR Health, Inc. (OSRH)

Aditxt, Inc. and OSR Health, Inc. are both Biotechnology companies. Aditxt, Inc. and OSR Health, Inc. are of similar size ($4.4M and $4.1M). OSR Health, Inc. grew revenue faster over the last twelve months: −50.2% against −74.2%. OSR Health, Inc. has the higher net margin (−1,093.4% vs −372,998.6%) and the lower return on invested capital (−8.19% vs 0.00%). Across the 15 metrics below, OSR Health, Inc. leads on 9 and Aditxt, Inc. on 6.

Valuation

Metric ADTX OSRH Biotechnology median
P/E n/m n/m 7.88
P/S n/m 4.00 11.47
P/B n/m 0.06 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 65.38 6.17 10.73
Earnings yield 0.00% (168.18%) (28.84%)
Free cash flow yield 0.00% (105.52%) (23.03%)

Profitability

Metric ADTX OSRH Biotechnology median
Gross margin 20.28% 35.29% 65.16%
Operating margin (128,143.36%) (933.72%) 0.00%
Net margin (372,998.60%) (1,093.41%) 0.00%
Free cash flow margin (129,979.72%) (398.26%) 0.00%
Return on equity 549.59% (14.98%) (57.72%)
Return on assets (236.38%) (11.24%) (49.22%)
Return on invested capital 0.00% (8.19%) 0.00%

Growth

Metric ADTX OSRH Biotechnology median
Revenue growth (TTM) (74.19%) (50.24%) 5.64%
EPS growth (last fiscal year) 99.99% 71.07% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADTX OSRH Biotechnology median
Debt to equity 0.00 0.04 0.00
Current ratio 0.06 0.18 4.73
Net debt to EBITDA 0.18 (0.29) 0.96

Dividend

Metric ADTX OSRH Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric ADTX OSRH Biotechnology median
Market cap 4.39m 4.09m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack